Clinical trials
Ventilation Acquired Pneumonia clinical trials
Below are recruiting ventilation acquired pneumonia clinical trials, each written for real people, not researchers. We’re tracking 37 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06602557RecruitingPhase 2
Inhaled antibiotic for lung infection during ECMO support
This trial tests whether adding an inhaled antibiotic (amikacin) to standard IV antibiotics can better treat a serious lung infection (pneumonia caused by Gram-negative bacteria) in patients on a heart-lung machine (ECMO) and a breathing tube. If you or your loved one is on ECMO and has this type of pneumonia, this study may offer a new treatment approach.
ParisAges 18 years+ - NCT06966310Recruiting
Awake prone positioning for community acquired pneumonia with high-flow oxygen
This trial tests whether lying on your stomach (prone position) while awake can help people with pneumonia breathe better and avoid needing a breathing tube. It is for patients in the ICU or step-down unit who need high-flow oxygen therapy.
AmiensAges 18 years+ - NCT06916481Recruiting
Pneumonia subtypes based on lung bacteria
This study looks at the germs in your lungs to understand why some people's pneumonia doesn't get better with standard antibiotics. If you are hospitalized with pneumonia and have just started treatment, you may be asked to provide a sputum sample so researchers can study your lung microbiome.
ClichyAges 18 years+ - NCT06269900RecruitingPhase 3
Dexamethasone for Severe Hospital-Acquired Pneumonia with Inflammation
This trial tests whether adding the anti-inflammatory drug dexamethasone to standard antibiotics improves recovery from severe hospital-acquired pneumonia in critically ill patients on a ventilator.
AmiensAges 18–85 - NCT05979545RecruitingPhase 4
Early treatment with ceftazidime-avibactam for serious infections
This study tests an antibiotic called ceftazidime-avibactam for people with serious infections like bloodstream infections or pneumonia that started in the hospital or from a breathing machine. It aims to start treatment quickly after identifying the bacteria.
Kuala LumpurAges Any age - NCT06602934Recruiting
Pneumonia, heart health, and your body's germs
This study looks at how pneumonia affects the long-term health of your heart and lungs by studying the germs that live in your body. It may help doctors understand why some people get worse and how to better protect your heart after a serious infection.
AngersAges 18–80 - NCT07453966Recruiting
Lung vibration therapy for people on breathing machines with lung infection
This study tests a device that delivers gentle vibrations to the lungs to help clear infection in people who are on a breathing machine. It may help improve oxygen levels and recovery.
Wuhan, HubeiAges 18 years+ - NCT05733104Recruiting
Study of Zavicefta safety after it’s used in Korea
This study looks at how the antibiotic Zavicefta is doing after it’s been approved and used by doctors in Korea. It may help confirm its safety and appropriate use for certain serious infections.
Seoul, Gangnam-guAges 3 months+ - NCT06294600RecruitingPhase 3
Clarithromycin to prevent sepsis in pneumonia
This study tests whether the antibiotic clarithromycin can prevent pneumonia from getting worse and turning into sepsis. It is for adults with community-acquired pneumonia who have certain signs of infection in their blood.
Athens, AthensAges 18 years+ - NCT06577558RecruitingPhase 2
SR1375 for severe pneumonia not improving on antibiotics
This trial tests a new drug called SR1375 for adults with severe community-acquired pneumonia (a lung infection) who are not improving with standard antibiotics. It may help reduce inflammation and speed up recovery.
Fuyang, AnhuiAges 18–85 - NCT07129174Recruiting
Lung bacteria changes in neurosurgery ICU patients with breathing tubes
This study looks at how tiny organisms in the lungs (the lung microbiome) change in neurosurgery patients who need a breathing tube in the ICU. It aims to see if these changes affect recovery or outcomes.
Beijing, Beijing MunicipalityAges 18 years+ - NCT03758508Recruiting
Noninvasive breathing support versus high-flow oxygen for pneumonia
This study compares two ways to help breathing in adults with pneumonia who have low oxygen levels: a noninvasive breathing machine versus high-flow oxygen. It aims to see which option helps patients breathe better and avoid getting worse.
MilanAges 18 years+ - NCT06999603RecruitingPhase 2
Inhaled study drug for virus infections on ventilators
This study tests an inhaled study drug (SNG001) for adults on a breathing machine in the ICU due to a viral lung infection. The goal is to see if the drug can help patients recover faster.
Sacramento, CaliforniaAges 18 years+
Hear when a new Ventilation Acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ventilation acquired pneumonia?
- Yes. Clin2 currently lists 37 recruiting ventilation acquired pneumonia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ventilation acquired pneumonia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ventilation acquired pneumonia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.